Xinlong Ma

952 total citations
27 papers, 768 citations indexed

About

Xinlong Ma is a scholar working on Molecular Biology, Cancer Research and Rheumatology. According to data from OpenAlex, Xinlong Ma has authored 27 papers receiving a total of 768 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 14 papers in Cancer Research and 7 papers in Rheumatology. Recurrent topics in Xinlong Ma's work include Cancer-related molecular mechanisms research (10 papers), MicroRNA in disease regulation (7 papers) and Cancer-related gene regulation (6 papers). Xinlong Ma is often cited by papers focused on Cancer-related molecular mechanisms research (10 papers), MicroRNA in disease regulation (7 papers) and Cancer-related gene regulation (6 papers). Xinlong Ma collaborates with scholars based in China and Japan. Xinlong Ma's co-authors include Changbao Chen, Jianxiong Ma, Jianwei Lv, Xiaolei Sun, Zhihu Zhao, Fengbo Li, Masahiro Mizoguchi, Koji Yoshimoto, Tomio Sasaki and Akira Nakamizo and has published in prestigious journals such as PLoS ONE, Clinical Cancer Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Xinlong Ma

27 papers receiving 763 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinlong Ma China 14 555 404 93 86 67 27 768
Chaofei Yang China 15 551 1.0× 339 0.8× 100 1.1× 67 0.8× 71 1.1× 23 889
Pinglin Lai China 16 530 1.0× 259 0.6× 148 1.6× 215 2.5× 54 0.8× 31 899
Pamela Swain United States 7 587 1.1× 304 0.8× 88 0.9× 62 0.7× 36 0.5× 13 888
Satoko Sunamura Japan 9 589 1.1× 388 1.0× 145 1.6× 44 0.5× 46 0.7× 11 858
Mengjun Ma China 14 382 0.7× 151 0.4× 90 1.0× 77 0.9× 51 0.8× 26 595
Lorraine Rose United Kingdom 12 385 0.7× 172 0.4× 133 1.4× 53 0.6× 33 0.5× 22 840
An‐Chen Chang Taiwan 20 565 1.0× 275 0.7× 232 2.5× 79 0.9× 130 1.9× 37 947
Guoli Hu China 15 560 1.0× 286 0.7× 131 1.4× 144 1.7× 29 0.4× 28 924
Yuanxin Zhu China 14 312 0.6× 151 0.4× 72 0.8× 89 1.0× 32 0.5× 33 600
Peng Deng United States 17 823 1.5× 311 0.8× 193 2.1× 52 0.6× 103 1.5× 20 1.2k

Countries citing papers authored by Xinlong Ma

Since Specialization
Citations

This map shows the geographic impact of Xinlong Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinlong Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinlong Ma more than expected).

Fields of papers citing papers by Xinlong Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinlong Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinlong Ma. The network helps show where Xinlong Ma may publish in the future.

Co-authorship network of co-authors of Xinlong Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Xinlong Ma. A scholar is included among the top collaborators of Xinlong Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinlong Ma. Xinlong Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gao, Min, Yue Song, Jing Liang, et al.. (2025). Sensitizing ferroptotic and apoptotic cancer therapy via tailored micelles-mediated coenzyme and ATP depletion under hypoxia. Journal of Controlled Release. 381. 113572–113572. 5 indexed citations
2.
Chen, Changbao, Hua Zhou, Xiaolin Zhang, Zhongjun Liu, & Xinlong Ma. (2022). Association of FBXW11 levels with tumor development and prognosis in chondrosarcoma. Cancer Biomarkers. 35(4). 429–437. 7 indexed citations
3.
Li, Guowang, Xuan Zhou, Lijun Tian, et al.. (2021). Identification of aberrantly methylated-differentially expressed genes and potential agents for Ewing sarcoma. Annals of Translational Medicine. 9(20). 1557–1557. 1 indexed citations
4.
Chen, Changbao, Hua Zhou, Zhongjun Liu, & Xinlong Ma. (2021). Dysregulation of Zinc Finger Protein 395 Contributes to the Pathogenesis of Chondrosarcoma. OncoTargets and Therapy. Volume 14. 3545–3553. 4 indexed citations
5.
Chen, Changbao, Hua Zhou, Xiaolin Zhang, Zhongjun Liu, & Xinlong Ma. (2021). Identification of ZNF704 as a Novel Oncogene and an Independent Prognostic Marker in Chondrosarcoma. Cancer Management and Research. Volume 13. 4911–4919. 5 indexed citations
6.
Ma, Jianxiong, et al.. (2021). Administration of tauroursodeoxycholic acid attenuates dexamethasone-induced skeletal muscle atrophy. Biochemical and Biophysical Research Communications. 570. 96–102. 10 indexed citations
7.
Chen, Changbao, Aixian Tian, Hua Zhou, et al.. (2020). <p>Upregulation of miR-211 Promotes Chondrosarcoma Development via Targeting Tumor Suppressor VHL</p>. OncoTargets and Therapy. Volume 13. 2935–2943. 6 indexed citations
8.
Chen, Changbao, Hua Zhou, Xiaolin Zhang, Zhongjun Liu, & Xinlong Ma. (2019). PRMT1 potentiates chondrosarcoma development through activation of YAP activity. Molecular Carcinogenesis. 58(12). 2193–2206. 11 indexed citations
9.
Chen, Changbao, Aixian Tian, Meng Zhao, & Xinlong Ma. (2018). Adenoviral delivery of VHL suppresses bone sarcoma cell growth through inhibition of Wnt/β-catenin signaling. Cancer Gene Therapy. 26(3-4). 83–93. 11 indexed citations
10.
Ma, Xinlong, et al.. (2018). MicroRNA-338-5p plays a tumor suppressor role in glioma through inhibition of the MAPK-signaling pathway by binding to FOXD1. Journal of Cancer Research and Clinical Oncology. 144(12). 2351–2366. 32 indexed citations
11.
Zhang, Xuedong, Yakui Zhang, Yong Mao, & Xinlong Ma. (2018). The lncRNA PCAT1 is correlated with poor prognosis and promotes cell proliferation, invasion, migration and EMT in osteosarcoma. OncoTargets and Therapy. Volume 11. 629–638. 39 indexed citations
12.
13.
Zhao, Bin, Zhihu Zhao, Xiaolei Sun, et al.. (2017). Effect of micro strain stress on proliferation of endothelial progenitor cells in vitro by the MAPK-ERK1/2 signaling pathway. Biochemical and Biophysical Research Communications. 492(2). 206–211. 6 indexed citations
14.
Song, Nan, Zhihu Zhao, Xinlong Ma, et al.. (2016). Naringin promotes fracture healing through stimulation of angiogenesis by regulating the VEGF/VEGFR-2 signaling pathway in osteoporotic rats. Chemico-Biological Interactions. 261. 11–17. 62 indexed citations
15.
Zhu, Shaowen, Jianpeng Li, Xinlong Ma, et al.. (2015). miR-9 Modulates Osteosarcoma Cell Growth by Targeting the GCIP Tumor Suppressor. Asian Pacific Journal of Cancer Prevention. 16(11). 4509–4513. 21 indexed citations
16.
Xiao, Liang & Xinlong Ma. (2014). The Influence of Government Intervention on Logistics Enterprise's Adoption of Information Technology. Journal of Digital Information Management. 12(1). 8–17. 3 indexed citations
17.
Chen, Changbao, Hua Zhou, Xiaolin Zhang, et al.. (2014). Elevated Levels of Dickkopf-1 Are Associated with β-Catenin Accumulation and Poor Prognosis in Patients with Chondrosarcoma. PLoS ONE. 9(8). e105414–e105414. 29 indexed citations
18.
Ma, Xinlong, Koji Yoshimoto, Nobuhiro Hata, et al.. (2012). Associations between microRNA expression and mesenchymal marker gene expression in glioblastoma. Neuro-Oncology. 14(9). 1153–1162. 60 indexed citations
19.
Chen, Changbao, Qingjun Ma, Xinlong Ma, Zhongjun Liu, & Xiaoguang Liu. (2011). Association of Elevated HIF-2α Levels with Low Beclin 1 Expression and Poor Prognosis in Patients with Chondrosarcoma. Annals of Surgical Oncology. 18(8). 2364–2372. 29 indexed citations
20.
Guan, Yanlei, Masahiro Mizoguchi, Koji Yoshimoto, et al.. (2010). MiRNA-196 Is Upregulated in Glioblastoma But Not in Anaplastic Astrocytoma and Has Prognostic Significance. Clinical Cancer Research. 16(16). 4289–4297. 156 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chaofei Yang Breakdown of academic impact, for papers by Pinglin Lai Breakdown of academic impact, for papers by Pamela Swain Breakdown of academic impact, for papers by Satoko Sunamura Breakdown of academic impact, for papers by Mengjun Ma Breakdown of academic impact, for papers by Lorraine Rose Breakdown of academic impact, for papers by An‐Chen Chang Breakdown of academic impact, for papers by Guoli Hu Breakdown of academic impact, for papers by Yuanxin Zhu Breakdown of academic impact, for papers by Peng Deng
Rankless by CCL
2026